Analyst Price Targets — PRVA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 26, 2026 12:58 pm | Andrew Mok | Barclays | $24.00 | $22.69 | TheFly | Privia Health price target lowered to $24 from $25 at Barclays |
| April 8, 2026 1:15 pm | — | Evercore ISI | $26.00 | $22.71 | TheFly | Privia Health price target lowered to $26 from $30 at Evercore ISI |
| February 26, 2026 8:26 pm | Jack Slevin | Jefferies | $32.00 | $24.91 | StreetInsider | Privia Health Group Inc (PRVA) PT Raised to $32 at Jefferies |
| February 26, 2026 7:34 pm | Jessica Tassan | Piper Sandler | $36.00 | $24.91 | StreetInsider | Privia Health Group Inc (PRVA) PT Raised to $36 at Piper Sandler |
| January 9, 2026 12:19 pm | — | RBC Capital | $31.00 | $23.15 | TheFly | Privia Health resumed with an Outperform at RBC Capital |
| January 6, 2026 9:57 am | — | Wolfe Research | $31.00 | $24.14 | StreetInsider | Privia Health Group (PRVA) Reiterated at Market Outperform by Citizens |
| November 12, 2025 12:02 pm | — | Canaccord Genuity | $34.00 | $24.32 | TheFly | Privia Health price target raised to $34 from $32 at Canaccord |
| October 9, 2025 9:49 am | — | Barclays | $22.00 | $24.53 | TheFly | Privia Health price target raised to $22 from $21 at Barclays |
| August 29, 2025 8:41 am | — | JMP Securities | $30.00 | $21.81 | TheFly | Privia Health price target raised to $30 from $29 at Citizens JMP |
| April 15, 2025 9:40 am | Michael Ha | Robert W. Baird | $26.00 | $24.10 | TheFly | Privia Health price target raised to $26 from $24 at Baird |
Latest News for PRVA
Former CEO Shawn Morris sold 135,498 shares on June 30 and July 1, 2026, generating proceeds of ~$3.57 million at a weighted average price around $26.32 per share. Morris' sale reduced direct ownership to 76,651 shares post-transaction.
ARLINGTON, Va., July 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its second-quarter and six-month periods ended June 30, 2026 before market open on Thursday, August 6, 2026.
CEO Parth Mehrotra sold 121,086 shares directly for a total of ~$2.73 million at an average price of around $22.56 per share across two days ending May 12, 2026. This transaction represented 21.80% of Mehrotra's direct holdings prior to the sale, reducing his direct position to 434,357 shares.
On June 04, 2026, Privia Health Group Inc (PRVA) shares rose 3.4% to a current price of $21.37. Over the past 52 weeks, the stock has traded between $18.77 and
Privia Health Group delivers technology-driven solutions to optimize physician practices and support value-based care nationwide.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for PRVA.
U.S. House Trading
No House trades found for PRVA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.